Biochemistry of amino acid racemization and clinical application to musculoskeletal disease

Clinical Biochemistry

Volumn 39, Issue 12, 2006, Pages 1112-1130

  McCudden, Christopher R ^a   Kraus, Virginia B ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarkers; Bone; Cartilage; Collagen; Deamidation; Isomerization; Musculoskeletal disease; Osteoarthritis; Racemization

Indexed keywords

AMINO ACID; BIOLOGICAL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE 2; PROTEIN; PROTEOGLYCAN;

AGE DETERMINATION; AMINO ACID ANALYSIS; BIOCHEMISTRY; CHEMICAL MODEL; CHIRALITY; CHROMATOGRAPHY; CLINICAL EFFECTIVENESS; DEAMINATION; DERIVATIZATION; DISEASE PREDISPOSITION; ENZYME CHEMISTRY; EPIDEMIOLOGICAL DATA; FORENSIC IDENTIFICATION; FUNCTIONAL ASSESSMENT; HISTOPATHOLOGY; HUMAN; IMMUNOLOGICAL PROCEDURES; ISOMERIZATION; MUSCULOSKELETAL DISEASE; PATHOLOGY; PH; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; RACEMIZATION; REVIEW; TEMPERATURE;

AGING; AMINO ACIDS; BIOLOGICAL MARKERS; COLLAGEN TYPE I; D-ASPARTIC ACID; FEMALE; FORENSIC SCIENCES; HUMANS; MALE; MIDDLE AGED; MUSCULOSKELETAL DISEASES; STEREOISOMERISM;

EID: 33751502231     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.07.009     Document Type: Review

References (210)

1. Cloos P.A., and Christgau S. Non-enzymatic covalent modifications of proteins: mechanisms, physiological consequences and clinical applications. Matrix Biol. 21 (2002) 39-52
2. Kvenvolden K., Lawless J., Pering K., Peterson E., Flores J., Ponnamperuma C., et al. Evidence for extraterrestrial amino-acids and hydrocarbons in the Murchison meteorite. Nature 228 (1970) 923-926
3. Ritz-Timme S., and Collins M.J. Racemization of aspartic acid in human proteins. Ageing Res. Rev. 1 (2002) 43-59
4. Smith Jr. W.T., and Kvenvolden K.A. Racemization and epimerization. Science 172 (1971) 403
5. Bada J.L., and McDonald G.D. Detecting amino acids on Mars. Anal. Chem. 68 (1996) 668A-673A
6. Bada J.L. State-of-the-art instruments for detecting extraterrestrial life. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 797-800
7. Skelley A.M., Scherer J.R., Aubrey A.D., Grover W.H., Ivester R.H., Ehrenfreund P., et al. Development and evaluation of a microdevice for amino acid biomarker detection and analysis on Mars. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1041-1046
8. Bada J.L., Luyendyk B.P., and Maynard J.B. Marine sediments: dating by the racemization of amino acids. Science 170 (1970) 730-732
9. Bada J.L., Schroeder R.A., Protsch R., and Berger R. Concordance of collagen-based radiocarbon and aspartic-acid racemization ages. Proc. Natl. Acad. Sci. U. S. A. 71 (1974) 914-917
10. Helfman P.M., and Bada J.L. Aspartic acid racemization in tooth enamel from living humans. Proc. Natl. Acad. Sci. U. S. A. 72 (1975) 2891-2894
11. Helfman P.M., and Bada J.L. Aspartic acid racemisation in dentine as a measure of ageing. Nature 262 (1976) 279-281
12. Helfman P.M., Bada J.L., and Shou M.Y. Considerations on the role of aspartic acid racemization in the aging process. Gerontology 23 (1977) 419-425
13. Masters P.M., Bada J.L., and Zigler Jr. J.S. Aspartic acid racemisation in the human lens during ageing and in cataract formation. Nature 268 (1977) 71-73
14. Masters P.M., Bada J.L., and Zigler Jr. J.S. Aspartic acid racemization in heavy molecular weight crystallins and water insoluble protein from normal human lenses and cataracts. Proc. Natl. Acad. Sci. U. S. A. 75 (1978) 1204-1208
15. Friedman M. Dietary impact of food processing. Annu. Rev. Nutr. 12 (1992) 119-137
16. Friedman M. Chemistry, nutrition, and microbiology of d-amino acids. J. Agric. Food Chem. 47 (1999) 3457-3479
17. Bada J.L. In vivo racemization in mammalian proteins. Methods Enzymol. 106 (1984) 98-115
18. Ohtani S., Yamada Y., Yamamoto T., Arany S., Gonmori K., and Yoshioka N. Comparison of age estimated from degree of racemization of aspartic acid, glutamic acid and alanine in the femur. J. Forensic Sci. 49 (2004) 441-445
19. Shah N.K., Brodsky B., Kirkpatrick A., and Ramshaw J.A. Structural consequences of d-amino acids in collagen triple-helical peptides. Biopolymers 49 (1999) 297-302
20. Clarke S. Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins. Int. J. Pept. Protein Res. 30 (1987) 808-821
21. Clarke S. Aging as war between chemical and biochemical processes: protein methylation and the recognition of age-damaged proteins for repair. Ageing Res. Rev. 2 (2003) 263-285
22. Geiger T., and Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J. Biol. Chem. 262 (1987) 785-794
23. Radkiewicz J.L., Zipse H., Clarke S., and Houk K.N. Accelerated racemization of aspartic acid and asparagine residues via succinimide intermediates: an ab initio theoretical exploration of mechanism. J. Am. Chem. Soc. 118 (1996) 9148-9155
24. Reissner K.J., and Aswad D.W. Deamidation and isoaspartate formation in proteins: unwanted alterations or surreptitious signals?. Cell. Mol. Life Sci. 60 (2003) 1281-1295
25. McFadden P.N., and Clarke S. Methylation at d-aspartyl residues in erythrocytes: possible step in the repair of aged membrane proteins. Proc. Natl. Acad. Sci. U. S. A. 79 (1982) 2460-2464
26. Robinson N.E., and Robinson A.B. Molecular clocks: deamidation of asparaginyl and glutaminyl residues in peptides and proteins (2004), Althouse Press, Cave Junction, OR Vol. ed.
27. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., et al. The protein data bank. Nucleic Acids Res. 28 (2000) 235-242
28. Capasso S., Di Donato A., Esposito L., Sica F., Sorrentino G., Vitagliano L., et al. Deamidation in proteins: the crystal structure of bovine pancreatic ribonuclease with an isoaspartyl residue at position 67. J. Mol. Biol. 257 (1996) 492-496
29. Capasso S., and Salvadori S. Effect of the three-dimensional structure on the deamidation reaction of ribonuclease A. J. Pept. Res. 54 (1999) 377-382
30. Fujii N., Momose Y., and Harada K. Kinetic study of racemization of aspartyl residues in model peptides of alpha A-crystallin. Int. J. Pept. Protein Res. 48 (1996) 118-122
31. Fujii N., Momose Y., Ishii N., Takita M., Akaboshi M., and Kodama M. The mechanisms of simultaneous stereoinversion, racemization, and isomerization at specific aspartyl residues of aged lens proteins. Mech. Ageing Dev. 107 (1999) 347-358
32. Potter S.M., Henzel W.J., and Aswad D.W. In vitro aging of calmodulin generates isoaspartate at multiple Asn-Gly and Asp-Gly sites in calcium-binding domains II, III, and IV. Protein Sci. 2 (1993) 1648-1663
33. Sandmeier E., Hunziker P., Kunz B., Sack R., and Christen P. Spontaneous deamidation and isomerization of Asn108 in prion peptide 106-126 and in full-length prion protein. Biochem. Biophys. Res. Commun. 261 (1999) 578-583
34. Radkiewicz J.L., Zipse H., Clarke S., and Houk K.N. Neighboring side chain effects on asparaginyl and aspartyl degradation: an ab initio study of the relationship between peptide conformation and backbone NH acidity. J. Am. Chem. Soc. 123 (2001) 3499-3506
35. Matsu'ura S., and Ueta N. Fraction dependent variation of aspartic acid racemization age of fossil bone. Nature 286 (1980) 883
36. van Duin A.C.T., and Collins M.J. The effects of conformational constraints on aspartic acid racemization. Org. Geochem. 29 (1998) 1227
37. Stephenson R.C., and Clarke S. Succinimide formation from aspartyl and asparaginyl peptides as a model for the spontaneous degradation of proteins. J. Biol. Chem. 264 (1989) 6164-6170
38. Ohtani S., Ito R., Arany S., and Yamamoto T. Racemization in enamel among different types of teeth from the same individual. Int. J. Leg. Med. 119 (2005) 66-69
39. Aswad D.W. Deamidation and Isoaspartate formation in peptides and proteins (1995), CRC Press, Boca Raton, FL Vol. ed.
40. Brennan T.V., and Clarke S. Spontaneous degradation of polypeptides at aspartyl and asparaginyl residues: effects of the solvent dielectric. Protein Sci. 2 (1993) 331-338
41. Oliyai C., and Borchardt R.T. Chemical pathways of peptide degradation: VI. Effect of the primary sequence on the pathways of degradation of aspartyl residues in model hexapeptides. Pharm. Res. 11 (1994) 751-758
42. Li C., and Thompson C.B. Cancer. DNA damage, deamidation, and death. Science 298 (2002) 1346-1347
43. Takehara T., and Takahashi H. Suppression of Bcl-xL deamidation in human hepatocellular carcinomas. Cancer Res. 63 (2003) 3054-3057
44. Wolosker H., Sheth K.N., Takahashi M., Mothet J.P., Brady Jr. R.O., Ferris C.D., et al. Purification of serine racemase: biosynthesis of the neuromodulator d-serine. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 721-725
45. Luthra M., Ranganathan D., Ranganathan S., and Balasubramanian D. Racemization of tyrosine in the insoluble protein fraction of brunescent aging human lenses. J. Biol. Chem. 269 (1994) 22678-22682
46. Cloos P.A., and Jensen A.L. Age-related de-phosphorylation of proteins in dentin: a biological tool for assessment of protein age. Biogerontology 1 (2000) 341-356
47. D'Aniello A., Vetere A., Fisher G.H., Cusano G., Chavez M., and Petrucelli L. Presence of d-alanine in proteins of normal and Alzheimer human brain. Brain Res. 592 (1992) 44-48
48. Fukushima T., Santa T., Homma H., Nagatomo R., and Imai K. Determination of d-amino acids in serum from patients with renal dysfunction. Biol. Pharm. Bull. 18 (1995) 1130-1132
49. Stabler T.V., Kong S.Y., Vail T.P., and Kraus V.B. Osteoarthritis research society international annual meeting, Boston, MA (2005)
50. Ritz-Timme S., Rochholz G., Schutz H.W., Collins M.J., Waite E.R., Cattaneo C., et al. Quality assurance in age estimation based on aspartic acid racemisation. Int. J. Leg. Med. 114 (2000) 83-86
51. Waite E.R., Collins M.J., and van Duin A.C. Hydroxyproline interference during the gas chromatographic analysis of d/l aspartic acid in human dentine. Int. J. Leg. Med. 112 (1999) 124-131
52. Williams K.M., and Smith G.G. A critical evaluation of the application of amino acid racemization to geochronology and geothermometry. Orig. Life 8 (1977) 91-144
53. Ohtani S., and Yamamoto T. Strategy for the estimation of chronological age using the aspartic acid racemization method with special reference to coefficient of correlation between d/l ratios and ages. J. Forensic Sci. 50 (2005) 1020-1027
54. Ritz-Timme S., Laumeier I., and Collins M.J. Aspartic acid racemization: evidence for marked longevity of elastin in human skin. Br. J. Dermatol. 149 (2003) 951-959
55. Bada J.L. Paleoanthropological applications of amino acid racemization dating of fossil bones and teeth. Anthropol. Anz. 45 (1987) 1-8
56. Bada J.L., Schroeder R.A., and Carter G.F. New evidence for the antiquity of man in North America deduced from aspartic acid racemization. Science 184 (1974) 791-793
57. Ohtani S., and Yamamoto K. Age estimation using the racemization of amino acid in human dentin. J. Forensic Sci. 36 (1991) 792-800
58. Pfeiffer H., Mornstad H., and Teivens A. Estimation of chronologic age using the aspartic acid racemization method: II. On human cortical bone. Int. J. Leg. Med. 108 (1995) 24-26
59. Ritz S., and Schutz H.W. Aspartic acid racemization in intervertebral discs as an aid to postmortem estimation of age at death. J. Forensic Sci. 38 (1993) 633-640
60. Masters P.M. Age at death determinations for autopsied remains based on aspartic acid racemization in tooth dentin: importance of postmortem conditions. Forensic Sci. Int. 32 (1986) 179-184
61. Ogino T., Ogino H., and Nagy B. Application of aspartic acid racemization to forensic odontology: post mortem designation of age at death. Forensic Sci. Int. 29 (1985) 259-267
62. Ohtani S. Rate of aspartic acid racemization in bone. Am. J. Forensic Med. Pathol. 19 (1998) 284-287
63. Ritz-Timme S., Cattaneo C., Collins M.J., Waite E.R., Schutz H.W., Kaatsch H.J., et al. Age estimation: the state of the art in relation to the specific demands of forensic practise. Int. J. Leg. Med. 113 (2000) 129-136
64. Maroudas A., Bayliss M.T., Uchitel-Kaushansky N., Schneiderman R., and Gilav E. Aggrecan turnover in human articular cartilage: use of aspartic acid racemization as a marker of molecular age. Arch. Biochem. Biophys. 350 (1998) 61-71
65. Maroudas A., Palla G., and Gilav E. Racemization of aspartic acid in human articular cartilage. Connect. Tissue Res. 28 (1992) 161-169
66. Bada J.L. Amino acid racemization dating of fossil bones. Annu. Rev. Earth Planet. Sci. 13 (1985) 241-268
67. Masters P.M., Bada J.L., and Samuel Zigler J. Aspartic acid racemisation in the human lens during ageing and in cataract formation. Nature 268 (1977) 71
68. Fujii N., Harada K., Momose Y., Ishii N., and Akaboshi M. d-Amino acid formation induced by a chiral field within a human lens protein during aging. Biochem. Biophys. Res. Commun. 263 (1999) 322-326
69. Fujii N., Ishibashi Y., Satoh K., Fujino M., and Harada K. Simultaneous racemization and isomerization at specific aspartic acid residues in alpha B-crystallin from the aged human lens. Biochim. Biophys. Acta 1204 (1994) 157-163
70. Fujii N., Matsumoto S., Hiroki K., and Takemoto L. Inversion and isomerization of Asp-58 residue in human alphaA-crystallin from normal aged lenses and cataractous lenses. Biochim. Biophys. Acta 1549 (2001) 179-187
71. Fujii N., Takemoto L.J., Momose Y., Matsumoto S., Hiroki K., and Akaboshi M. Formation of four isomers at the asp-151 residue of aged human alphaA-crystallin by natural aging. Biochem. Biophys. Res. Commun. 265 (1999) 746-751
72. Fujii N., Satoh K., Harada K., and Ishibashi Y. Simultaneous stereoinversion and isomerization at specific aspartic acid residues in alpha A-crystallin from human lens. J. Biochem. (Tokyo) 116 (1994) 663-669
73. Fujii N. d-amino acid in elderly tissues. Biol. Pharm. Bull. 28 (2005) 1585-1589
74. Fujii N., Tajima S., Tanaka N., Fujimoto N., Takata T., and Shimo-Oka T. The presence of d-beta-aspartic acid-containing peptides in elastic fibers of sun-damaged skin: a potent marker for ultraviolet-induced skin aging. Biochem. Biophys. Res. Commun. 294 (2002) 1047-1051
75. Kuge K., Fujii N., Miura Y., Tajima S., and Saito T. Kinetic study of racemization of aspartyl residues in synthetic elastin peptides. Amino Acids 27 (2004) 193-197
76. Shapiro S.D., Endicott S.K., Province M.A., Pierce J.A., and Campbell E.J. Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of d-aspartate and nuclear weapons-related radiocarbon. J. Clin. Invest. 87 (1991) 1828-1834
77. Harkness E.F., Macfarlane G.J., Silman A.J., and McBeth J. Is musculoskeletal pain more common now than 40 years ago?: Two population-based cross-sectional studies. Rheumatology (Oxford) 44 (2005) 890-895
78. Leveille S.G. Musculoskeletal aging. Curr. Opin. Rheumatol. 16 (2004) 114-118
79. Picavet H.S., and Hazes J.M. Prevalence of self reported musculoskeletal diseases is high. Ann. Rheum. Dis. 62 (2003) 644-650
80. Kean W.F., and Buchanan W.W. The use of NSAIDs in rheumatic disorders 2005: a global perspective. Inflammopharmacology 13 (2005) 343-370
81. Woolf A.D., and Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 81 (2003) 646-656
82. Gineyts E., Cloos P.A., Borel O., Grimaud L., Delmas P.D., and Garnero P. Racemization and isomerization of type I collagen C-telopeptides in human bone and soft tissues: assessment of tissue turnover. Biochem. J. 345 Pt 3 (2000) 481-485
83. Clarke S. Protein carboxyl methyltransferases: two distinct classes of enzymes. Annu. Rev. Biochem. 54 (1985) 479-506
84. Weber D.J., and McFadden P.N. Injury-induced enzymatic methylation of aging collagen in the extracellular matrix of blood vessels. J. Protein. Chem. 16 (1997) 269-281
85. Garnero P., and Delmas P.D. Biomarkers in osteoarthritis. Curr. Opin. Rheumatol. 15 (2003) 641-646
86. Robins S.P. Collagen turnover in bone diseases. Curr. Opin. Clin. Nutr. Metab. Care 6 (2003) 65-71
87. Wotton S.F., Dieppe P.A., and Duance V.C. Type IX collagen immunoreactive peptides in synovial fluids from arthritis patients. Rheumatology (Oxford) 38 (1999) 338-345
88. Calvo M.S., Eyre D.R., and Gundberg C.M. Molecular basis and clinical application of biological markers of bone turnover. Endocr. Rev. 17 (1996) 333-368
89. Bonde M., Fledelius C., Qvist P., and Christiansen C. Coated-tube radioimmunoassay for C-telopeptides of type I collagen to assess bone resorption. Clin. Chem. 42 (1996) 1639-1644
90. Bonde M., Qvist P., Fledelius C., Riis B.J., and Christiansen C. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin. Chem. 40 (1994) 2022-2025
91. Fledelius C., Johnsen A.H., Cloos P.A., Bonde M., and Qvist P. Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) region. J. Biol. Chem. 272 (1997) 9755-9763
92. Garnero P., Fledelius C., Gineyts E., Serre C.M., Vignot E., and Delmas P.D. Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone. J. Bone Miner. Res. 12 (1997) 1407-1415
93. Garnero P., Gineyts E., Schaffer A.V., Seaman J., and Delmas P.D. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease. Arthritis Rheum. 41 (1998) 354-360
94. Cloos P.A., Fledelius C., Christgau S., Christiansen C., Engsig M., Delmas P., et al. Investigation of bone disease using isomerized and racemized fragments of type I collagen. Calcif. Tissue Int. 72 (2003) 8-17
95. Alexandersen P., Peris P., Guanabens N., Byrjalsen I., Alvarez L., Solberg H., et al. Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone. J. Bone Miner. Res. 20 (2005) 588-595
96. Cloos P.A., Christgau S., Lyubimova N., Body J.J., Qvist P., and Christiansen C. Breast cancer patients with bone metastases are characterised by increased levels of nonisomerised type I collagen fragments. Breast Cancer Res. 5 (2003) R103-R109
97. Cloos P.A., and Fledelius C. Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential. Biochem. J. 345 Pt 3 (2000) 473-480
98. Garnero P., Cloos P., Sornay-Rendu E., Qvist P., and Delmas P.D. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study. J. Bone Miner. Res. 17 (2002) 826-833
99. Brady J.D., Ju J., and Robins S.P. Isoaspartyl bond formation within N-terminal sequences of collagen type I: implications for their use as markers of collagen degradation. Clin. Sci. (Lond) 96 (1999) 209-215
100. Rapaka R.S., Bhatnagar R.S., and Nitecki D.E. Racemization in the synthesis of polytripeptide models of a collagen. Biopolymers 15 (1976) 317-324
101. Garnero P., Borel O., Gineyts E., Duboeuf F., Solberg H., Bouxsein M.L., et al. Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone. Bone (2005)
102. Lanthier J., Bouthillier A., Lapointe M., Demeule M., Beliveau R., and Desrosiers R.R. Down-regulation of protein l-isoaspartyl methyltransferase in human epileptic hippocampus contributes to generation of damaged tubulin. J. Neurochem. 83 (2002) 581-591
103. Charni N., Juillet F., and Garnero P. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 52 (2005) 1081-1090
104. Eyre D. Collagen of articular cartilage. Arthritis Res. 4 (2002) 30-35
105. Eyre D.R. Collagens and cartilage matrix homeostasis. Clin. Orthop. Relat. Res. (2004) S118-S122
106. Garnero P., Conrozier T., Christgau S., Mathieu P., Delmas P.D., and Vignon E. Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis. Ann. Rheum. Dis. 62 (2003) 939-943
107. Aigner T., Zhu Y., Chansky H.H., Matsen III F.A., Maloney W.J., and Sandell L.J. Reexpression of type IIA procollagen by adult articular chondrocytes in osteoarthritic cartilage. Arthritis Rheum. 42 (1999) 1443-1450
108. Billinghurst R.C., Dahlberg L., Ionescu M., Reiner A., Bourne R., Rorabeck C., et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J. Clin. Invest. 99 (1997) 1534-1545
109. Lohmander L.S., Yoshihara Y., Roos H., Kobayashi T., Yamada H., and Shinmei M. Procollagen II C-propeptide in joint fluid: changes in concentration with age, time after knee injury, and osteoarthritis. J. Rheumatol. 23 (1996) 1765-1769
110. Elsaid K.A., and Chichester C.O. Review: collagen markers in early arthritic diseases. Clin. Chim. Acta (2005)
111. Deberg M., Labasse A., Christgau S., Cloos P., Bang Henriksen D., Chapelle J.P., et al. New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis. Osteoarthr. Cartil. 13 (2005) 258-265
112. Henrotin Y., Deberg M., Dubuc J.E., Quettier E., Christgau S., and Reginster J.Y. Type II collagen peptides for measuring cartilage degradation. Biorheology 41 (2004) 543-547
113. Gelse K., Soder S., Eger W., Diemtar T., and Aigner T. Osteophyte development-molecular characterization of differentiation stages. Osteoarthr. Cartil. 11 (2003) 141-148
114. Kiani C., Chen L., Wu Y.J., Yee A.J., and Yang B.B. Structure and function of aggrecan. Cell Res. 12 (2002) 19-32
115. Knudson C.B., and Knudson W. Cartilage proteoglycans. Semin. Cell Dev. Biol. 12 (2001) 69-78
116. Watanabe H., Yamada Y., and Kimata K. Roles of aggrecan, a large chondroitin sulfate proteoglycan, in cartilage structure and function. J. Biochem. (Tokyo) 124 (1998) 687-693
117. Cloos P.A., and Christgau S. Characterization of aged osteocalcin fragments derived from bone resorption. Clin. Lab. 50 (2004) 585-598
118. Ritz S., Turzynski A., and Schutz H.W. Estimation of age at death based on aspartic acid racemization in noncollagenous bone proteins. Forensic Sci. Int. 69 (1994) 149-159
119. Ritz S., Turzynski A., Schutz H.W., Hollmann A., and Rochholz G. Identification of osteocalcin as a permanent aging constituent of the bone matrix: basis for an accurate age at death determination. Forensic Sci. Int. 77 (1996) 13-26
120. Guo Y., Bozic D., Malashkevich V.N., Kammerer R.A., Schulthess T., and Engel J. All-trans retinol, vitamin D and other hydrophobic compounds bind in the axial pore of the five-stranded coiled-coil domain of cartilage oligomeric matrix protein. EMBO J. 17 (1998) 5265-5272
121. Ozbek S., Engel J., and Stetefeld J. Storage function of cartilage oligomeric matrix protein: the crystal structure of the coiled-coil domain in complex with vitamin D(3). EMBO J. 21 (2002) 5960-5968
122. Clark A.G., Jordan J.M., Vilim V., Renner J.B., Dragomir A.D., Luta G., et al. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project. Arthritis Rheum. 42 (1999) 2356-2364
123. Vilim V., Olejarova M., Machacek S., Gatterova J., Kraus V.B., and Pavelka K. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthr. Cartil. 10 (2002) 707-713
124. Vilim V., Voburka Z., Vytasek R., Senolt L., Tchetverikov I., Kraus V.B., et al. Monoclonal antibodies to human cartilage oligomeric matrix protein: epitope mapping and characterization of sandwich ELISA. Clin. Chim. Acta 328 (2003) 59-69
125. Cloos P.A., and Christgau S. Post-translational modifications of proteins: implications for aging, antigen recognition, and autoimmunity. Biogerontology 5 (2004) 139-158
126. Fabian H., Szendrei G.I., Mantsch H.H., Greenberg B.D., and Otvos Jr. L. Synthetic post-translationally modified human A beta peptide exhibits a markedly increased tendency to form beta-pleated sheets in vitro. Eur. J. Biochem. 221 (1994) 959-964
127. Mizuno A., Fujii N., Akaboshi M., Momose Y., and Shimo-oka T. Changes of secondary structure detected by laser Raman spectroscopy in model peptides of human alphaA-crystallin due to substitution of d-aspartyl residues for l-aspartyl residues. Jpn. J. Ophthalmol. 44 (2000) 354-359
128. Orpiszewski J., and Benson M.D. Induction of beta-sheet structure in amyloidogenic peptides by neutralization of aspartate: a model for amyloid nucleation. J. Mol. Biol. 289 (1999) 413-428
129. Szendrei G.I., Fabian H., Mantsch H.H., Lovas S., Nyeki O., Schon I., et al. Aspartate-bond isomerization affects the major conformations of synthetic peptides. Eur. J. Biochem. 226 (1994) 917-924
130. Szendrei G.I., Prammer K.V., Vasko M., Lee V.M., and Otvos Jr. L. The effects of aspartic acid-bond isomerization on in vitro properties of the amyloid beta-peptide as modeled with N-terminal decapeptide fragments. Int. J. Pept. Protein Res. 47 (1996) 289-296
131. Fujii N., Momose Y., Ishibashi Y., Uemura T., Takita M., and Takehana M. Specific racemization and isomerization of the aspartyl residue of alphaA-crystallin due to UV-B irradiation. Exp. Eye Res. 65 (1997) 99-104
132. Fujii N., Muraoka S., and Harada K. Purification and characterization of a protein containing d-aspartic acid in bovine lens. Biochim. Biophys. Acta 999 (1989) 239-242
133. Fujii N., Uchida H., and Saito T. The damaging effect of UV-C irradiation on lens alpha-crystallin. Mol. Vis. 10 (2004) 814-820
134. Zhang Y., Wu D.R., Wang-Iverson D.B., and Tymiak A.A. Enantioselective chromatography in drug discovery. Drug Discov. Today 10 (2005) 571-577
135. Ritz S., Stock R., Schutz H.W., and Kaatsch H.J. Age estimation in biopsy specimens of dentin. Int. J. Leg. Med. 108 (1995) 135-139
136. Helfman P.M., and Bada J.L. Aspartic acid racemization in tooth enamel from living humans. Proc. Natl. Acad. Sci. U. S. A. 72 (1975) 2891-2894
137. Ohtani S. Different racemization ratios in dentin from different locations within a tooth. Growth Dev. Aging 61 (1997) 93-99
138. Ohtani S., Kato S., and Sugeno H. Changes in d-aspartic acid in human deciduous teeth with age from 1-20 years. Growth Dev. Aging 60 (1996) 1-6
139. Waite E.R., Collins M.J., Ritz-Timme S., Schutz H.W., Cattaneo C., and Borrman H.I. A review of the methodological aspects of aspartic acid racemization analysis for use in forensic science. Forensic Sci. Int. 103 (1999) 113-124
140. Iida T., Santa T., Toriba A., and Imai K. Amino acid sequence and d/l-configuration determination methods for d-amino acid-containing peptides in living organisms. Biomed. Chromatogr. 15 (2001) 319-327
141. Iida T., Matsunaga H., Santa T., Fukushima T., Homma H., and Imai K. Amino acid sequence and d/l-configuration determination of peptides utilizing liberated N-terminus phenylthiohydantoin amino acids. J. Chromatogr., A 813 (1998) 267-275
142. D'Aniello A., D'Onofrio G., Pischetola M., D'Aniello G., Vetere A., Petrucelli L., et al. Biological role of d-amino acid oxidase and d-aspartate oxidase. Effects of d-amino acids. J. Biol. Chem. 268 (1993) 26941-26949
143. Caldinelli L., Motteran L., Sacchi S., Piubelli L., Boselli A., Mothet J.P., et al. Detection of d-amino acids by d-amino acid oxidase. d-Amino acids: a new frontier in amino acid and protein research-Practical methods and protocols (2006), Nova Science Publishers, New York, U.S.A. Vol. ed.
144. Fisher G.H., D'Aniello A., Vetere A., Padula L., Cusano G.P., and Man E.H. Free d-aspartate and d-alanine in normal and Alzheimer brain. Brain Res. Bull. 26 (1991) 983-985
145. Nagata Y., Borghi M., Fisher G.H., and D'Aniello A. Free d-serine concentration in normal and Alzheimer human brain. Brain Res. Bull. 38 (1995) 181-183
146. Bergmeyer H.U. Methods of enzymatic analysis,. 2nd ed. (1974) Vol.
147. Mothet J.P., Pollegioni L., Ouanounou G., Martineau M., Fossier P., and Baux G. Glutamate receptor activation triggers a calcium-dependent and SNARE protein-dependent release of the gliotransmitter d-serine. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 5606-5611
148. Johnson B.A., and Aswad D.W. Optimal conditions for the use of protein l-isoaspartyl methyltransferase in assessing the isoaspartate content of peptides and proteins. Anal. Biochem. 192 (1991) 384-391
149. Carlson A.D., and Riggin R.M. Development of improved high-performance liquid chromatography conditions for nonisotopic detection of isoaspartic acid to determine the extent of protein deamidation. Anal. Biochem. 278 (2000) 150-155
150. Schurter B.T., and Aswad D.W. Analysis of isoaspartate in peptides and proteins without the use of radioisotopes. Anal. Biochem. 282 (2000) 227-231
151. Johnson B.A., Shirokawa J.M., Hancock W.S., Spellman M.W., Basa L.J., and Aswad D.W. Formation of isoaspartate at two distinct sites during in vitro aging of human growth hormone. J. Biol. Chem. 264 (1989) 14262-14271
152. Young A.L., Carter W.G., Doyle H.A., Mamula M.J., and Aswad D.W. Structural integrity of histone H2B in vivo requires the activity of protein l-isoaspartate O-methyltransferase, a putative protein repair enzyme. J. Biol. Chem. 276 (2001) 37161-37165
153. Young G.W., Hoofring S.A., Mamula M.J., Doyle H.A., Bunick G.J., Hu Y., et al. Protein l-isoaspartyl methyltransferase catalyzes in vivo racemization of aspartate-25 in mammalian histone H2B. J. Biol. Chem. 280 (2005) 26094-26098
154. Aswad D.W., Paranandi M.V., and Schurter B.T. Isoaspartate in peptides and proteins: formation, significance, and analysis. J. Pharm. Biomed. Anal. 21 (2000) 1129-1136
155. Paranandi M.V., Guzzetta A.W., Hancock W.S., and Aswad D.W. Deamidation and isoaspartate formation during in vitro aging of recombinant tissue plasminogen activator. J. Biol. Chem. 269 (1994) 243-253
156. Franks M.E., Macpherson G.R., and Figg W.D. Thalidomide. Lancet 363 (2004) 1802-1811
157. Christgau S., Rosenquist C., Alexandersen P., Bjarnason N.H., Ravn P., Fledelius C., et al. Clinical evaluation of the Serum CrossLaps One ELISA. Step, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides. Clin. Chem. 44 (1998) 2290-2300
158. Cloos P.A., Lyubimova N., Solberg H., Qvist P., Christiansen C., Byrjalsen I., et al. An immunoassay for measuring fragments of newly synthesized collagen type I produced during metastatic invasion of bone. Clin. Lab. 50 (2004) 279-289
159. Rosenquist C., Bonde M., Fledelius C., and Qvist P. A simple enzyme-linked immunosorbent assay of human osteocalcin. Clin. Chem. 40 (1994) 1258-1264
160. Rosenquist C., Fledelius C., Christgau S., Pedersen B.J., Bonde M., Qvist P., et al. Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Clin. Chem. 44 (1998) 2281-2289
161. Lee J.A., Homma H., Sakai K., Fukushima T., Santa T., Tashiro K., et al. Immunohistochemical localization of d-aspartate in the rat pineal gland. Biochem. Biophys. Res. Commun. 231 (1997) 505-508
162. Sakai K., Homma H., Lee J.A., Fukushima T., Santa T., Tashiro K., et al. d-aspartic acid localization during postnatal development of rat adrenal gland. Biochem. Biophys. Res. Commun. 235 (1997) 433-436
163. Sakai K., Homma H., Lee J.A., Fukushima T., Santa T., Tashiro K., et al. Emergence of d-aspartic acid in the differentiating neurons of the rat central nervous system. Brain Res. 808 (1998) 65-71
164. Sakai K., Homma H., Lee J.A., Fukushima T., Santa T., Tashiro K., et al. Localization of d-aspartic acid in elongate spermatids in rat testis. Arch. Biochem. Biophys. 351 (1998) 96-105
165. Got P.A., and Scherrmann J.M. Stereoselectivity of antibodies for the bioanalysis of chiral drugs. Pharm. Res. 14 (1997) 1516-1523
166. DeGroot J. The AGE of the matrix: chemistry, consequence and cure. Curr. Opin. Pharmacol. 4 (2004) 301-305
167. Li S.Y., Du M., Dolence E.K., Fang C.X., Mayer G.E., Ceylan-Isik A.F., et al. Aging induces cardiac diastolic dysfunction, oxidative stress, accumulation of advanced glycation endproducts and protein modification. Aging Cell 4 (2005) 57-64
168. DeGroot J., Bank R.A., Tchetverikov I., Verzijl N., and TeKoppele J.M. Molecular markers for osteoarthritis: the road ahead. Curr. Opin. Rheumatol. 14 (2002) 585-589
169. DeGroot J., Verzijl N., Wenting-van Wijk M.J., Jacobs K.M., Van El B., Van Roermund P.M., et al. Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. Arthritis Rheum. 50 (2004) 1207-1215
170. Verzijl N., Bank R.A., TeKoppele J.M., and DeGroot J. AGEing and osteoarthritis: a different perspective. Curr. Opin. Rheumatol. 15 (2003) 616-622
171. Iwatsubo T., Saido T.C., Mann D.M., Lee V.M., and Trojanowski J.Q. Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques. Am. J. Pathol. 149 (1996) 1823-1830
172. Kaneko I., Morimoto K., and Kubo T. Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [d-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments. Neuroscience 104 (2001) 1003-1011
173. Kubo T., Kumagae Y., Miller C.A., and Kaneko I. Beta-amyloid racemized at the Ser26 residue in the brains of patients with Alzheimer disease: implications in the pathogenesis of Alzheimer disease. J. Neuropathol. Exp. Neurol. 62 (2003) 248-259
174. Kubo T., Nishimura S., Kumagae Y., and Kaneko I. In vivo conversion of racemized beta-amyloid ([d-Ser 26]A beta 1-40) to truncated and toxic fragments ([d-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients. J. Neurosci. Res. 70 (2002) 474-483
175. Kuo Y.M., Kokjohn T.A., Beach T.G., Sue L.I., Brune D., Lopez J.C., et al. Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains. J. Biol. Chem. 276 (2001) 12991-12998
176. Roher A.E., Lowenson J.D., Clarke S., Wolkow C., Wang R., Cotter R.J., et al. Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J. Biol. Chem. 268 (1993) 3072-3083
177. Shapira R., Austin G.E., and Mirra S.S. Neuritic plaque amyloid in Alzheimer's disease is highly racemized. J. Neurochem. 50 (1988) 69-74
178. Shimizu T., Fukuda H., Murayama S., Izumiyama N., and Shirasawa T. Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease. J. Neurosci. Res. 70 (2002) 451-461
179. David C.L., Orpiszewski J., Zhu X.C., Reissner K.J., and Aswad D.W. Isoaspartate in chrondroitin sulfate proteoglycans of mammalian brain. J. Biol. Chem. 273 (1998) 32063-32070
180. Orpiszewski J., and Aswad D.W. High mass methyl-accepting protein (HMAP), a highly effective endogenous substrate for protein l-isoaspartyl methyltransferase in mammalian brain. J. Biol. Chem. 271 (1996) 22965-22968
181. Man E.H., Sandhouse M.E., Burg J., and Fisher G.H. Accumulation of d-aspartic acid with age in the human brain. Science 220 (1983) 1407-1408
182. Fisher G.H., Garcia N.M., Payan I.L., Cadilla-Perezrios R., Sheremata W.A., and Man E.H. d-aspartic acid in purified myelin and myelin basic protein. Biochem. Biophys. Res. Commun. 135 (1986) 683-687
183. Fisher G.H., Payan I.L., Chou S.J., Man E.H., Cerwinski S., Martin T., et al. Racemized d-aspartate in Alzheimer neurofibrillary tangles. Brain Res. Bull. 28 (1992) 127-131
184. Payan I.L., Chou S.J., Fisher G.H., Man E.H., Emory C., and Frey II W.H. Altered aspartate in Alzheimer neurofibrillary tangles. Neurochem. Res. 17 (1992) 187-191
185. Kenessey A., Yen S.H., Liu W.K., Yang X.R., and Dunlop D.S. Detection of d-aspartate in tau proteins associated with Alzheimer paired helical filaments. Brain Res. 675 (1995) 183-189
186. Fisher G.H., D'Aniello A., Vetere A., Cusano G.P., Chavez M., and Petrucelli L. Quantification of d-aspartate in normal and Alzheimer brains. Neurosci. Lett. 143 (1992) 215-218
187. Najbauer J., Orpiszewski J., and Aswad D.W. Molecular aging of tubulin: accumulation of isoaspartyl sites in vitro and in vivo. Biochemistry 35 (1996) 5183-5190
188. Pfeiffer H., Mornstad H., and Teivens A. Estimation of chronologic age using the aspartic acid racemization method: I. On human rib cartilage. Int. J. Leg. Med. 108 (1995) 19-23
189. Brunauer L.S., and Clarke S. Age-dependent accumulation of protein residues which can be hydrolyzed to d-aspartic acid in human erythrocytes. J. Biol. Chem. 261 (1986) 12538-12543
190. Ingrosso D., and Perna A.F. d-amino acids in aging erythrocytes. Exs 85 (1998) 119-141
191. O'Connor C.M., Aswad D.W., and Clarke S. Mammalian brain and erythrocyte carboxyl methyltransferases are similar enzymes that recognize both d-aspartyl and l-isoaspartyl residues in structurally altered protein substrates. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 7757-7761
192. Fujii N., Takeuchi N., Fujii N., Tezuka T., Kuge K., Takata T., et al. Comparison of post-translational modifications of alpha A-crystallin from normal and hereditary cataract rats. Amino Acids 26 (2004) 147-152
193. Groenen P.J., van den Ijssel P.R., Voorter C.E., Bloemendal H., and de Jong W.W. Site-specific racemization in aging alpha A-crystallin. FEBS Lett. 269 (1990) 109-112
194. Groenen P.J., van Dongen M.J., Voorter C.E., Bloemendal H., and de Jong W.W. Age-dependent deamidation of alpha B-crystallin. FEBS Lett. 322 (1993) 69-72
195. Voorter C.E., de Haard-Hoekman W.A., van den Oetelaar P.J., Bloemendal H., and de Jong W.W. Spontaneous peptide bond cleavage in aging alpha-crystallin through a succinimide intermediate. J. Biol. Chem. 263 (1988) 19020-19023
196. Ball L.E., Garland D.L., Crouch R.K., and Schey K.L. Post-translational modifications of aquaporin 0 (AQP0) in the normal human lens: spatial and temporal occurrence. Biochemistry 43 (2004) 9856-9865
197. Powell J.T., Vine N., and Crossman M. On the accumulation of d-aspartate in elastin and other proteins of the ageing aorta. Atherosclerosis 97 (1992) 201-208
198. Kinzel V., Konig N., Pipkorn R., Bossemeyer D., and Lehmann W.D. The amino terminus of PKA catalytic subunit-A site for introduction of posttranslational heterogeneities by deamidation: d-Asp2 and d-isoAsp2 containing isozymes. Protein Sci. 9 (2000) 2269-2277
199. di Salvo M.L., Fratte DelleS., Maras B., Bossa F., Wright H.T., and Schirch V. Deamidation of asparagine residues in a recombinant serine hydroxymethyltransferase. Arch. Biochem. Biophys. 372 (1999) 271-279
200. Ohtani S. Studies on age estimation using racemization of aspartic acid in cementum. J. Forensic Sci. 40 (1995) 805-807
201. Wittwer-Backofen U., Gampe J., and Vaupel J.W. Tooth cementum annulation for age estimation: results from a large known-age validation study. Am. J. Phys. Anthropol. 123 (2004) 119-129
202. Masters P.M. Stereochemically altered noncollagenous protein from human dentin. Calcif. Tissue Int. 35 (1983) 43-47
203. Ohtani S. Estimation of age from dentin by utilizing the racemization of aspartic acid: influence of pH. Forensic Sci. Int. 75 (1995) 181-187
204. Aswad D.W. Stoichiometric methylation of porcine adrenocorticotropin by protein carboxyl methyltransferase requires deamidation of asparagine 25. Evidence for methylation at the alpha-carboxyl group of atypical l-isoaspartyl residues. J. Biol. Chem. 259 (1984) 10714-10721
205. Johnson B.A., and Aswad D.W. Fragmentation of isoaspartyl peptides and proteins by carboxypeptidase Y: release of isoaspartyl dipeptides as a result of internal and external cleavage. Biochemistry 29 (1990) 4373-4380
206. Johnson B.A., Freitag N.E., and Aswad D.W. Protein carboxyl methyltransferase selectively modifies an atypical form of calmodulin. Evidence for methylation at deamidated asparagine residues. J. Biol. Chem. 260 (1985) 10913-10916
207. Johnson B.A., Langmack E.L., and Aswad D.W. Partial repair of deamidation-damaged calmodulin by protein carboxyl methyltransferase. J. Biol. Chem. 262 (1987) 12283-12287
208. Moss C.X., Matthews S.P., Lamont D.J., and Watts C. Asparagine deamidation perturbs antigen presentation on class II major histocompatibility complex molecules. J. Biol. Chem. 280 (2005) 18498-18503
209. Yuan P.M., Talent J.M., and Gracy R.W. Molecular basis for the accumulation of acidic isozymes of triosephosphate isomerase on aging. Mech. Ageing Dev. 17 (1981) 151-162
210. Yuksel K.U., and Gracy R.W. In vitro deamidation of human triosephosphate isomerase. Arch. Biochem. Biophys. 248 (1986) 452-459